{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,24]],"date-time":"2026-09-24T13:23:09Z","timestamp":1790256189181,"version":"4.1.0"},"reference-count":46,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2018,5,1]],"date-time":"2018-05-01T00:00:00Z","timestamp":1525132800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2018,5,1]],"date-time":"2018-05-01T00:00:00Z","timestamp":1525132800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2018,5,1]],"date-time":"2018-05-01T00:00:00Z","timestamp":1525132800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2018,5,1]],"date-time":"2018-05-01T00:00:00Z","timestamp":1525132800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2018,5,1]],"date-time":"2018-05-01T00:00:00Z","timestamp":1525132800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2018,5,1]],"date-time":"2018-05-01T00:00:00Z","timestamp":1525132800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2018,5,1]],"date-time":"2018-05-01T00:00:00Z","timestamp":1525132800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["International Journal of Drug Policy"],"published-print":{"date-parts":[[2018,5]]},"DOI":"10.1016\/j.drugpo.2018.03.017","type":"journal-article","created":{"date-parts":[[2018,3,27]],"date-time":"2018-03-27T00:56:13Z","timestamp":1522112173000},"page":"149-154","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":15,"special_numbering":"C","title":["Surveillance of sexualised drug use \u2013 the challenges and the opportunities"],"prefix":"10.1016","volume":"55","author":[{"given":"Isabelle","family":"Giraudon","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Axel Jeremias","family":"Schmidt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2060-7286","authenticated-orcid":false,"given":"Hamish","family":"Mohammed","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"9","key":"10.1016\/j.drugpo.2018.03.017_bib0005","doi-asserted-by":"crossref","first-page":"e431","DOI":"10.1016\/S2352-3018(16)30037-6","article-title":"Sexual behaviours, HIV testing, and the proportion of men at risk of transmitting and acquiring HIV in London, UK, 2000-13: A serial cross-sectional study","volume":"3","author":"Aghaizu","year":"2016","journal-title":"The Lancet HIV"},{"issue":"5","key":"10.1016\/j.drugpo.2018.03.017_bib0010","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1016\/j.therap.2016.04.003","article-title":"Usage de psychostimulants dans un contexte sexuel: analyse des cas rapport\u00e9s au R\u00e9seau fran\u00e7ais des centres d\u2019addictovigilance. \u00c9valuation des risques li\u00e9s \u00e0 la pratique du SLAM","volume":"71","author":"Batisse","year":"2016","journal-title":"Th\u00e8rapie"},{"key":"10.1016\/j.drugpo.2018.03.017_bib0015","series-title":"The Chemsex study: drug use in sexual settings among gay and bisexual men in Lambeth, Southwark and Lewisham\u2019, Sigma Research","author":"Bourne","year":"2014"},{"key":"10.1016\/j.drugpo.2018.03.017_bib0020","series-title":"EMCDDA commissioned paper for the Health and social responses to drug problems: A European guide","article-title":"Joining up sexual health and drug services to better meet client needs","author":"Bowden-Jones","year":"2017"},{"issue":"5","key":"10.1016\/j.drugpo.2018.03.017_bib0025","doi-asserted-by":"crossref","first-page":"e5690","DOI":"10.1371\/journal.pone.0005690","article-title":"HIV-1 superinfection in the antiretroviral therapy era: Are seroconcordant sexual partners at risk?","volume":"4","author":"Campbell","year":"2009","journal-title":"PLoS One"},{"key":"10.1016\/j.drugpo.2018.03.017_bib0030","series-title":"2013 UK national guideline for consultations requiring sexual history taking","author":"Clinical Effectiveness Group \u2013 British Association for Sexual Health and HIV","year":"2013"},{"issue":"6","key":"10.1016\/j.drugpo.2018.03.017_bib0035","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1136\/sti.2004.011171","article-title":"Sexual trauma associated with fisting and recreational drugs","volume":"80","author":"Cohen","year":"2004","journal-title":"Sexually Transmitted Infections"},{"issue":"2","key":"10.1016\/j.drugpo.2018.03.017_bib0040","doi-asserted-by":"crossref","DOI":"10.1093\/jscr\/2012.2.3","article-title":"Successful laparoscopic repair of a large traumatic sigmoid perforation","volume":"2012","author":"de Bakker","year":"2012","journal-title":"Journal of Surgical Case Reports"},{"key":"10.1016\/j.drugpo.2018.03.017_bib0045","doi-asserted-by":"crossref","DOI":"10.1016\/j.drugpo.2018.02.002","article-title":"Sexualised drug use in the United Kingdom (UK): A review of the literature","author":"Edmundson","year":"2018","journal-title":"Under Review \u2013 International Journal of Drug Policy"},{"key":"10.1016\/j.drugpo.2018.03.017_bib0050","series-title":"Technical report \u2212 STI and HIV prevention in men who have sex with men in Europe","author":"European Centre for Disease Prevention and Control","year":"2013"},{"key":"10.1016\/j.drugpo.2018.03.017_bib0055","series-title":"Gonorrhoea \u2013 Annual Epidemiological Report 2016 [2014 data]","author":"European Centre for Disease Prevention and Control","year":"2016"},{"key":"10.1016\/j.drugpo.2018.03.017_bib0060","series-title":"Syphilis \u2013 Annual Epidemiological Report 2016 [2014 data]","author":"European Centre for Disease Prevention and Control","year":"2016"},{"key":"10.1016\/j.drugpo.2018.03.017_bib0065","series-title":"HIV\/AIDS surveillance in Europe.2016 data","author":"European Centre for Disease Prevention and Control, & World Health Organisation Regional Office for Europe","year":"2017"},{"key":"10.1016\/j.drugpo.2018.03.017_bib0070","series-title":"Understanding the impact of smartphone applications on the sexual health of men who have sex with men and HIV prevention in Europe. Meeting report","author":"European Centre for Disease Prevention and Control and Terrence Higgins Trust","year":"2015"},{"key":"10.1016\/j.drugpo.2018.03.017_bib0075","unstructured":"European ChemSex Forum, (2018). 2nd European ChemSex Forum (22\u201324 March, 2018; Berlin). Available at: http:\/\/www.profbriefings.co.uk\/chemsex2018\/. Accessed 5th January 2018."},{"key":"10.1016\/j.drugpo.2018.03.017_bib0080","series-title":"New psychoactive substances in Europe. An update from the EU Early Warning System March 2015","author":"European Monitoring Centre for Drugs and Drug Addiction","year":"2015"},{"key":"10.1016\/j.drugpo.2018.03.017_bib0085","series-title":"Recent changes in Europe\u2019s MDMA\/ecstasy market","author":"European Monitoring Centre for Drugs and Drug Addiction","year":"2016"},{"key":"10.1016\/j.drugpo.2018.03.017_bib0090","series-title":"Drug-related infectious diseases in Europe: Update from the EMCDDA expert network","author":"European Monitoring Centre for Drugs and Drug Addiction","year":"2017"},{"key":"10.1016\/j.drugpo.2018.03.017_bib0095","series-title":"European Drug Report 2017: Trends and Developments, Publications Office of the European Union","author":"European Monitoring Centre for Drugs and Drug Addiction","year":"2017"},{"key":"10.1016\/j.drugpo.2018.03.017_bib0100","series-title":"High-risk drug use and new psychoactive substances","author":"European Monitoring Centre for Drugs and Drug Addiction","year":"2017"},{"issue":"3","key":"10.1016\/j.drugpo.2018.03.017_bib0105","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1136\/sti.2006.023283","article-title":"Men who have sex with men in Great Britain: comparison of a self-selected internet sample with a national probability sample","volume":"83","author":"Evans","year":"2007","journal-title":"Sexually Transmitted Infections"},{"issue":"2","key":"10.1016\/j.drugpo.2018.03.017_bib0110","first-page":"311","article-title":"Increasing Rates of Sexually Transmitted Diseases in Homosexual Men in Western Europe and the United States: Why?","volume":"19","author":"Fenton","year":"2005","journal-title":"Infectious Disease Clinics"},{"issue":"9466","key":"10.1016\/j.drugpo.2018.03.017_bib0115","doi-asserted-by":"crossref","first-page":"1246","DOI":"10.1016\/S0140-6736(05)74813-3","article-title":"Ethnic variations in sexual behaviour in Great Britain and risk of sexually transmitted infections: a probability survey","volume":"365","author":"Fenton","year":"2005","journal-title":"The Lancet"},{"key":"10.1016\/j.drugpo.2018.03.017_bib0120","doi-asserted-by":"crossref","DOI":"10.1136\/sextrans-2015-052014","article-title":"Sex, drugs and smart phone applications: findings from semistructured interviews with men who have sex with men diagnosed with Shigella flexneri 3a in England and Wales","author":"Gilbart","year":"2015","journal-title":"Sexually Transmitted Infections"},{"issue":"11","key":"10.1016\/j.drugpo.2018.03.017_bib0125","doi-asserted-by":"crossref","first-page":"1314","DOI":"10.1086\/656809","article-title":"Frequency and Determinants of Unprotected Sex among HIV-Infected Persons: The Swiss HIV Cohort Study","volume":"51","author":"Hasse","year":"2010","journal-title":"Clinical Infectious Diseases"},{"issue":"4","key":"10.1016\/j.drugpo.2018.03.017_bib0130","doi-asserted-by":"crossref","first-page":"362","DOI":"10.1177\/0956462416651229","article-title":"Chemsex and the city: Sexualised substance use in gay bisexual and other men who have sex with men attending sexual health clinics","volume":"28","author":"Hegazi","year":"2017","journal-title":"International Journal of STD & AIDS"},{"issue":"Suppl. C","key":"10.1016\/j.drugpo.2018.03.017_bib0135","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1016\/j.forsciint.2016.11.039","article-title":"An observed rise in \u03b3-hydroxybutyrate-associated deaths in London: Evidence to suggest a possible link with concomitant rise in chemsex","volume":"270","author":"Hockenhull","year":"2017","journal-title":"Forensic Science International"},{"issue":"1","key":"10.1016\/j.drugpo.2018.03.017_bib0140","doi-asserted-by":"crossref","first-page":"35","DOI":"10.2217\/fmb.14.110","article-title":"The epidemiology of sexually transmitted infections in the UK: impact of behavior, services and interventions","volume":"10","author":"Hughes","year":"2015","journal-title":"Future Microbiology"},{"issue":"1","key":"10.1016\/j.drugpo.2018.03.017_bib0145","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1186\/1477-7517-8-16","article-title":"Drug Checking: A prevention measure for a heterogeneous group with high consumption frequency and polydrug use \u2013 evaluation of zurich's drug checking services","volume":"8","author":"Hungerbuehler","year":"2011","journal-title":"Harm Reduction Journal"},{"issue":"642","key":"10.1016\/j.drugpo.2018.03.017_bib0150","doi-asserted-by":"crossref","first-page":"4","DOI":"10.3399\/bjgp16X683029","article-title":"Safer \u2018chemsex\u2019: GPs\u2019 role in harm reduction for emerging forms of recreational drug use","volume":"66","author":"Ma","year":"2016","journal-title":"British Journal of General Practice"},{"key":"10.1016\/j.drugpo.2018.03.017_bib0155","series-title":"CHEMSEX, SLAM Renouvellement des usages de drogues en contextes sexuels parmi les HSH [Renewal of drug use in sexual context among MSM] Thema Trend OFDT","author":"Milhet","year":"2017"},{"issue":"Suppl. C","key":"10.1016\/j.drugpo.2018.03.017_bib0160","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1016\/j.toxlet.2017.05.030","article-title":"Intoxication by gamma hydroxybutyrate and related analogues: Clinical characteristics and comparison between pure intoxication and that combined with other substances of abuse","volume":"277","author":"Mir\u00f3","year":"2017","journal-title":"Toxicology Letters"},{"issue":"6","key":"10.1016\/j.drugpo.2018.03.017_bib0165","doi-asserted-by":"crossref","first-page":"454","DOI":"10.1136\/sextrans-2016-052740","article-title":"Sexualised drug use in people attending sexual health clinics in England","volume":"92","author":"Mohammed","year":"2016","journal-title":"Sexually Transmitted Infections"},{"issue":"7","key":"10.1016\/j.drugpo.2018.03.017_bib0170","doi-asserted-by":"crossref","first-page":"626","DOI":"10.1016\/j.drugpo.2015.04.003","article-title":"Fentanyls: Are we missing the signs? Highly potent and on the rise in Europe","volume":"26","author":"Mounteney","year":"2015","journal-title":"International Journal of Drug Policy"},{"issue":"8","key":"10.1016\/j.drugpo.2018.03.017_bib0175","doi-asserted-by":"crossref","first-page":"568","DOI":"10.1136\/sextrans-2015-052405","article-title":"How to assess gay, bisexual and other men who have sex with men for chemsex","volume":"92","author":"Pakianathan","year":"2016","journal-title":"Sexually Transmitted Infections"},{"issue":"Suppl. C","key":"10.1016\/j.drugpo.2018.03.017_bib0180","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1016\/j.drugpo.2016.10.004","article-title":"New psychoactive substances: Current health-related practices and challenges in responding to use and harms in Europe","volume":"40","author":"Pirona","year":"2017","journal-title":"International Journal of Drug Policy"},{"key":"10.1016\/j.drugpo.2018.03.017_bib0185","series-title":"Substance misuse services for men who have sex with men involved in chemsex","author":"Public Health England","year":"2015"},{"key":"10.1016\/j.drugpo.2018.03.017_bib0190","series-title":"Adult substance misuse statistics from the National Drug Treatment Monitoring System (NDTMS)","author":"Public Health England","year":"2017"},{"issue":"2","key":"10.1016\/j.drugpo.2018.03.017_bib0195","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1001\/jama.2016.5148","article-title":"Sexual activity without condoms and risk of hiv transmission in serodifferent couples when the hiv-positive partner is using suppressive antiretroviral therapy","volume":"316","author":"Rodger","year":"2016","journal-title":"JAMA"},{"key":"10.1016\/j.drugpo.2018.03.017_bib0200","article-title":"Improving surveillance of sexually transmitted infections using mandatory electronic clinical reporting: The genitourinary medicine clinic activity dataset, England, 2009 to 2013","volume":"48","author":"Savage","year":"2014","journal-title":"Euro Surveillance"},{"issue":"Suppl. C","key":"10.1016\/j.drugpo.2018.03.017_bib0205","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1016\/j.drugpo.2016.09.007","article-title":"Illicit drug use among gay and bisexual men in 44 cities: Findings from the European MSM Internet Survey (EMIS)","volume":"38","author":"Schmidt","year":"2016","journal-title":"International Journal of Drug Policy"},{"issue":"4","key":"10.1016\/j.drugpo.2018.03.017_bib0210","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1080\/13691058.2010.550322","article-title":"Let's talk about sex: Helping substance abuse counsellors address HIV prevention with men who have sex with men","volume":"13","author":"Spector","year":"2011","journal-title":"Culture, Health & Sexuality"},{"key":"10.1016\/j.drugpo.2018.03.017_bib0215","first-page":"24","article-title":"ChemSex and care-planning: One year in practice","volume":"15","author":"Stuart","year":"2015","journal-title":"HIV Nursing"},{"issue":"3","key":"10.1016\/j.drugpo.2018.03.017_bib0220","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1258\/0956462021924884","article-title":"HIV treatments optimism is associated with unprotected anal intercourse with regular and with casual partners among Australian gay and homosexually active men","volume":"13","author":"Van de Ven","year":"2002","journal-title":"International Journal of STD & AIDS"},{"key":"10.1016\/j.drugpo.2018.03.017_bib0225","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1016\/j.drugpo.2017.05.018","article-title":"The utility of drug checking services as monitoring tools and more: A response to Pirona et al","volume":"45","author":"Gin\u00e9","year":"2017","journal-title":"International Journal of Drug Policy"},{"issue":"4","key":"10.1016\/j.drugpo.2018.03.017_bib0230","doi-asserted-by":"crossref","first-page":"239","DOI":"10.3109\/15563650.2014.898771","article-title":"The European drug emergencies network (Euro-DEN)","volume":"52","author":"Wood","year":"2014","journal-title":"Clinical Toxicology"}],"container-title":["International Journal of Drug Policy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0955395918300872?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0955395918300872?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,9,15]],"date-time":"2026-09-15T11:36:38Z","timestamp":1789472198000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0955395918300872"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,5]]},"references-count":46,"alternative-id":["S0955395918300872"],"URL":"https:\/\/doi.org\/10.1016\/j.drugpo.2018.03.017","relation":{},"ISSN":["0955-3959"],"issn-type":[{"value":"0955-3959","type":"print"}],"subject":[],"published":{"date-parts":[[2018,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Surveillance of sexualised drug use \u2013 the challenges and the opportunities","name":"articletitle","label":"Article Title"},{"value":"International Journal of Drug Policy","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.drugpo.2018.03.017","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Crown Copyright \u00a9 2018 Published by Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}